The FREEDOM trial: In appropriate patients with diabetes and multivessel coronary artery disease, CABG beats PCIAugust 1, 2013Diabetes
Controversial diabetes drug not associated with increased CV risk in patients with CADJuly 30, 2013Diabetes
